Table 1.
Summary of Study Outcomes and Procedures by Domain
| Domain | Outcome | Procedure |
|---|---|---|
| Cardiorespiratory fitness | Peak oxygen consumption O2 pulse |
Cardiopulmonary exercise testing |
| Sarcopenia | Sarcopenia Per European Working Group on Sarcopenia (Cruz-Jentoft et al., 2010) | DXA + grip strength; DXA + gait speed |
| Frailty | Frailty phenotype (Schmaltz et al., 2005) VACS index (Tate et al., 2019) |
Gait speed + grip strength Clinical laboratory values |
| Health-related QoL | Symptoms, including pain and fatigue Social inclusion Mobility and working capacity |
WHOQOL-HIV (O’Connell & Skevington, 2012) |
| Social factors | Social support Self-efficacy |
Exercise Social Provisions Scale (Courneya & McAuley, 2016) Barriers-Specific Efficacy Questionnaire (McAuley et al., 2003) |
| Evaluation | Video technology Personal barriers Intervention fidelity |
System Usability Scale (Bangor et al., 2008) Reasons for attrition/missed visits % AEX time at target heart rate |
Note. AEX = aerobic exercise; DXA = dual-energy X-ray absorptiometry; QoL = quality of life.